Vertex Securities: Board Approves Q2 FY27 Unaudited Financials, Appoints New Director

Vertex Securities Limited announced that its Board of Directors, in a meeting held on October 28, 2026, approved the unaudited financial results for the quarter and half-year ended September 30, 2026. The Board also approved the appointment of Ms. Prameela Unni as a Non-Executive Independent Woman Director and Mr. Venkitesh Iyer as Chief Financial Officer.

Vertex Securities Board Meeting Outcome

Vertex Securities Limited convened a Board of Directors meeting on Wednesday, October 28, 2026. During this meeting, the Board took several significant decisions, including the approval of the Company’s unaudited financial results for the quarter and half-year ended September 30, 2026. These results, both standalone and consolidated, have been accompanied by a Limited Review Report, as detailed in Annexure I.

Key Appointments Approved

Further to financial matters, the Board also approved two key appointments to strengthen its governance and leadership structure. Firstly, Ms. Prameela Unni has been appointed as a Non-Executive Independent Woman Director. Her tenure is set to commence from October 30, 2026, for a term of five years, subject to shareholder approval. Ms. Unni brings extensive experience in marketing and financial services, including a significant role at Abu Dhabi Commercial Bank.

Secondly, Mr. Venkitesh Iyer, who currently serves as Company Secretary & Compliance Officer, has been appointed as the Chief Financial Officer of the Company. This appointment is effective from October 28, 2026. Mr. Iyer has a background in company secretarial and legal affairs with expertise in various financial regulations and compliance matters.

Meeting Details and Disclosures

The Board meeting commenced at 11:30 A.M. and concluded at 17:09 P.M. Detailed disclosures regarding these matters are provided in the attached annexures as required by the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Source: BSE

Previous Article

Dr. Reddy's Laboratories: USFDA Concludes Srikakulam Plant Inspection with VAI Classification

Next Article

Honasa Consumer: Approves Amalgamation of Subsidiaries